 |
|
Smallpox, Bioterrorism, and the Neurologist
Dennis J. Cleri, MD;
Francisco J. Villota, MD;
Richard B. Porwancher, MD
Arch Neurol. 2003;60:489-494.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
Smallpox virus, used as a weapon against an unimmunized population, has the potential to infect tens of thousands of individuals, kill 30% or more of those infected, and trigger the vaccination of many times that number.1 The neurologist will be faced with recognizing and treating the neurologic complications of both the disease and the vaccine.1-2 As the most serious untoward reaction to the vaccine is fatal encephalitis, the neurologist will be central to the debate over whether the government should consider a national campaign to reimmunize the population or wait until there is a terrorist attack involving this agent as a single entity or in combination with another virus, bacteria, and/or chemical or nuclear agents.2-3 This review discusses the recent history, virology, epidemiology, pathogenesis, clinical manifestations of smallpox and smallpox vaccine (vaccinia virus), and preventive strategies with special . . . [Full Text of this Article]
SMALLPOX (VARIOLA) VIRUS: CLASSIFICATION AND HISTORY
EPIDEMIOLOGY AND PATHOLOGY
CLINICAL MANIFESTATIONS
Incubation Period Typical Clinical Disease (Variola Major) Clinical Spectrum (Variola Major) Variola Sine Eruptione (Variola Sine Exanthemata) Encephalitis and Other Complications
CHEMOTHERAPY
VACCINATION
CONTROL OF THE EPIDEMIC
From the Internal Medicine Residency Program (Drs Cleri and Villota) and the Division of Infectious Diseases (Dr Porwancher), St Francis Medical Center, Trenton, NJ; and the Departments of Medicine, Seton Hall University School of Graduate Medical Education, South Orange, NJ (Dr Cleri), and University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick (Dr Porwancher).
|
